Overview Dividends

(VTR) Ventas - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US92276F1003

Senior Housing, Medical Buildings, Research Centers, Healthcare Facilities

EPS (Earnings per Share)

EPS (Earnings per Share) of VTR over the last years for every Quarter: "2020-09": 0.03, "2020-12": 0.29, "2021-03": -0.15, "2021-06": 0.23, "2021-09": 0.16, "2021-12": -0.1, "2022-03": 0.1, "2022-06": -0.11, "2022-09": 0.0031, "2022-12": -0.11, "2023-03": 0.04, "2023-06": 0.18, "2023-09": -0.18, "2023-12": -0.23, "2024-03": -0.03, "2024-06": 0.05, "2024-09": 0.05, "2024-12": 0.13, "2025-03": 0.1, "2025-06": 0.15, "2025-09": 0.121,
EPS Growth (3y CAGR): 44.58%
EPS Trend (3y Corr): 51.6%
Last SUE: 0.15σ
Qual. Beats: 0

Revenue

Revenue of VTR over the last years for every Quarter: 2020-09: 918.94, 2020-12: 921.165, 2021-03: 910.291, 2021-06: 919.194, 2021-09: 976.078, 2021-12: 1022.444, 2022-03: 1017.554, 2022-06: 1022.938, 2022-09: 1037.276, 2022-12: 1051.425, 2023-03: 1077.245, 2023-06: 1106.358, 2023-09: 1149.832, 2023-12: 1164.392, 2024-03: 1199.914, 2024-06: 1200.98, 2024-09: 1236.315, 2024-12: 1287.057, 2025-03: 1358.074, 2025-06: 1420.893, 2025-09: 1488.996,
Revenue Growth (3y CAGR): 13.49%
Revenue Trend (3y Corr): 98.2%
Last SUE: 3.72σ
Qual. Beats: 5
Risk via 10d forecast
Volatility 18.1%
Value at Risk 5%th 30.3%
Relative Tail Risk -5.42%
Reward TTM
Sharpe Ratio 1.03
Alpha 19.64
Character TTM
Hurst Exponent 0.277
Beta 0.277
Beta Downside 0.399
Drawdowns 3y
Max DD 22.88%
Mean DD 7.31%
Median DD 6.00%

Description: VTR Ventas October 14, 2025

Ventas, Inc. (NYSE: VTR) is a S&P 500-listed REIT focused on health-care real estate, operating roughly 1,400 properties across North America and the United Kingdom. Its core assets are more than 850 senior-housing communities, complemented by outpatient medical buildings, research centers, and other health-care facilities, positioning the company within the expanding “longevity economy.”

Key operational metrics show a FY 2023 occupancy rate of ~94% across senior-housing assets and a FY 2023 Funds-From-Operations (FFO) growth of 5% year-over-year, supporting a current dividend yield of about 5.5%. The portfolio’s performance is closely tied to macro drivers such as the U.S. aging demographic (projected to add ~10 million adults aged 65+ by 2030) and the prevailing interest-rate environment, which influences REIT cap rates and borrowing costs.

For investors seeking deeper quantitative insight, exploring ValueRay’s proprietary analytics on Ventas’ cash-flow sensitivity to interest-rate shifts can reveal hidden upside or downside scenarios worth further investigation.

VTR Stock Overview

Market Cap in USD 36,639m
Sub-Industry Health Care REITs
IPO / Inception 1998-05-04
Return 12m vs S&P 500 11.2%
Analyst Rating 4.45 of 5

VTR Dividends

Metric Value
Dividend Yield 2.39%
Yield on Cost 5y 4.63%
Yield CAGR 5y -4.27%
Payout Consistency 96.5%
Payout Ratio 3.8%

VTR Growth Ratios

Metric Value
CAGR 3y 26.05%
CAGR/Max DD Calmar Ratio 1.14
CAGR/Mean DD Pain Ratio 3.57
Current Volume 1829.3k
Average Volume 2703.2k

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (56.8m TTM) > 0 and > 6% of Revenue (6% = 333.3m TTM)
FCFTA 0.04 (>2.0%) and ΔFCFTA 1.19pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 1.29% (prev 6.51%; Δ -5.22pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.06 (>3.0%) and CFO 1.55b > Net Income 56.8m (YES >=105%, WARN >=100%)
Net Debt (12.61b) to EBITDA (2.08b) ratio: 6.05 <= 3.0 (WARN <= 3.5)
Current Ratio 1.61 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (456.4m) change vs 12m ago 8.80% (target <= -2.0% for YES)
Gross Margin 22.97% (prev 12.08%; Δ 10.89pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 21.25% (prev 18.94%; Δ 2.31pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 1.06 (EBITDA TTM 2.08b / Interest Expense TTM 752.5m) >= 6 (WARN >= 3)

Altman Z'' -1.21

(A) 0.00 = (Total Current Assets 188.6m - Total Current Liabilities 117.0m) / Total Assets 26.93b
(B) -0.27 = Retained Earnings (Balance) -7.37b / Total Assets 26.93b
(C) 0.03 = EBIT TTM 794.5m / Avg Total Assets 26.14b
(D) -0.52 = Book Value of Equity -7.29b / Total Liabilities 14.15b
Total Rating: -1.21 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 62.82

1. Piotroski 5.0pt = 0.0
2. FCF Yield 2.34% = 1.17
3. FCF Margin 20.74% = 5.19
4. Debt/Equity 1.04 = 1.99
5. Debt/Ebitda 6.05 = -2.50
6. ROIC - WACC (= -2.41)% = -3.01
7. RoE 0.49% = 0.04
8. Rev. Trend 98.25% = 7.37
9. EPS Trend 51.59% = 2.58

What is the price of VTR shares?

As of November 19, 2025, the stock is trading at USD 79.00 with a total of 1,829,330 shares traded.
Over the past week, the price has changed by +3.99%, over one month by +11.87%, over three months by +18.36% and over the past year by +27.39%.

Is VTR a buy, sell or hold?

Ventas has received a consensus analysts rating of 4.45. Therefore, it is recommended to buy VTR.
  • Strong Buy: 12
  • Buy: 5
  • Hold: 3
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the VTR price?

Issuer Target Up/Down from current
Wallstreet Target Price 79.9 1.1%
Analysts Target Price 79.9 1.1%
ValueRay Target Price 92.1 16.6%

VTR Fundamental Data Overview November 15, 2025

Market Cap USD = 36.64b (36.64b USD * 1.0 USD.USD)
P/E Trailing = 144.4444
P/E Forward = 131.5789
P/S = 6.6087
P/B = 2.935
P/EG = 1.7374
Beta = 0.802
Revenue TTM = 5.56b USD
EBIT TTM = 794.5m USD
EBITDA TTM = 2.08b USD
Long Term Debt = 12.57b USD (from longTermDebt, last quarter)
Short Term Debt = 107.3m USD (from shortTermDebt, last quarter)
Debt = 12.86b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 12.61b USD (from netDebt column, last quarter)
Enterprise Value = 49.31b USD (36.64b + Debt 12.86b - CCE 188.6m)
Interest Coverage Ratio = 1.06 (Ebit TTM 794.5m / Interest Expense TTM 752.5m)
FCF Yield = 2.34% (FCF TTM 1.15b / Enterprise Value 49.31b)
FCF Margin = 20.74% (FCF TTM 1.15b / Revenue TTM 5.56b)
Net Margin = 1.02% (Net Income TTM 56.8m / Revenue TTM 5.56b)
Gross Margin = 22.97% ((Revenue TTM 5.56b - Cost of Revenue TTM 4.28b) / Revenue TTM)
Gross Margin QoQ = -29.31% (prev 41.80%)
Tobins Q-Ratio = 1.83 (Enterprise Value 49.31b / Total Assets 26.93b)
Interest Expense / Debt = 2.33% (Interest Expense 299.7m / Debt 12.86b)
Taxrate = -6.34% (negative due to tax credits) (6.34m / -100.1m)
NOPAT = 844.9m (EBIT 794.5m * (1 - -6.34%)) [negative tax rate / tax credits]
Current Ratio = 1.61 (Total Current Assets 188.6m / Total Current Liabilities 117.0m)
Debt / Equity = 1.04 (Debt 12.86b / totalStockholderEquity, last quarter 12.36b)
Debt / EBITDA = 6.05 (Net Debt 12.61b / EBITDA 2.08b)
Debt / FCF = 10.95 (Net Debt 12.61b / FCF TTM 1.15b)
Total Stockholder Equity = 11.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.21% (Net Income 56.8m / Total Assets 26.93b)
RoE = 0.49% (Net Income TTM 56.8m / Total Stockholder Equity 11.53b)
RoCE = 3.30% (EBIT 794.5m / Capital Employed (Equity 11.53b + L.T.Debt 12.57b))
RoIC = 3.45% (NOPAT 844.9m / Invested Capital 24.50b)
WACC = 5.86% (E(36.64b)/V(49.49b) * Re(7.04%) + D(12.86b)/V(49.49b) * Rd(2.33%) * (1-Tc(-0.06)))
Discount Rate = 7.04% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 5.90%
[DCF Debug] Terminal Value 79.93% ; FCFE base≈1.00b ; Y1≈1.13b ; Y5≈1.52b
Fair Price DCF = 56.25 (DCF Value 26.42b / Shares Outstanding 469.7m; 5y FCF grow 14.74% → 3.0% )
EPS Correlation: 51.59 | EPS CAGR: 44.58% | SUE: 0.15 | # QB: 0
Revenue Correlation: 98.25 | Revenue CAGR: 13.49% | SUE: 3.72 | # QB: 5

Additional Sources for VTR Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle